Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 3Unknown 2Not yet recruiting 2Completed 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Head & Neck 2

Conditions

Carcinoma, Non-Small-Cell Lung 13Stomach Neoplasms 12Colorectal Neoplasms 8Breast Neoplasms 8Esophageal Neoplasms 7Rectal Neoplasms 6Lung Neoplasms 6Carcinoma, Hepatocellular 6Glioblastoma 5Brain Neoplasms 5Neoplasms 4Neoplasm Metastasis 4Colonic Neoplasms 4Cholangiocarcinoma 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Lymphatic Metastasis 3Glioma 3Endometrial Neoplasms 3Disease 3Astrocytoma 3Thyroid Neoplasms 2Recurrence 2Pain, Postoperative 2Oropharyngeal Neoplasms 2Melanoma 2Laryngeal Neoplasms 2Gliosarcoma 2Gastrointestinal Stromal Tumors 2

Interventions

Thyroidectomy 4Iodine-131 4trametinib 3dabrafenib 3apatinib 3anlotinib 2Surgical Procedures, Operative 2Blood Specimen Collection 2Biopsy, Large-Core Needle 2toripalimab 1tislelizumab 1surufatinib 1regorafenib 1penpulimab 1pembrolizumab 1pazopanib 1palbociclib 1olaparib 1lenvatinib 1famitinib 1camrelizumab 1Ultrasonography 1Thyroxine 1Thyrotropin Alfa 1Sunitinib 1Second Harmonic Generation Microscopy 1Routinely Collected Health Data 1Rosiglitazone 1Robotic Surgical Procedures 1Radiotherapy, Intensity-Modulated 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Thyroid Neoplasms × Surgical Procedures, Operative × Clear all
NCT04309136 2021-04-01

Anlotinib Neoadjuvant Treatment in Locally Advanced Thyroid Cancer

Fudan University

Phase 2 Unknown
13 enrolled
Head & Neck

Thyroid Neoplasms

NCT04612894 2020-11-03

Camrelizumab and Apatinib for Neoadjuvant Therapy in Thyroid Cancer

Fudan University

Phase 2 Unknown
31 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡